Top 50 Medical Startup Investors in Israel in May 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Israel. We rank investors based on the number of investments they made in Medical companies from Israel. We update this investor list every month.Top 50 Medical Startup Investors in Israel in May 2025
Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Series A, Seed
- Israel, United States, New Zealand
Portfolio highlights
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- Kando — Kando is an end-to-end solution that creates continuous awareness of events in the collection system. Kando enables utilities to remotely and continuously improve their operations by providing the following features:• Realtime wastewater quality data across the collection system • Pinpoint sources of pollution • Early warnings of damaging WWTPinfluent quality • Machine learning that evolves with your network • Autonomous sampling units • User fee calculator • Customized pollution alerts • A user-friendly, online interface • Detection of COVID-19 infection rates (New)The combination of these actionable insights results in:• Reduced CAPEX/OPEX • Greater WW reuse capabilities • Improved public health • Cleaner environmentsKando has been deployed in Los Angeles, Milan, Brisbane, and many other cities. To gain a greater understanding of how our system can help your organization, visit our homepage at www.kando.eco.
- Blue Tree Technologies Ltd. — Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, Israel, France
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
- Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series A, Series B
- Israel
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more
Investment focus
- Health Care, Wellness, Food and Beverage
- Series A, Seed, Series B
- United States, United Kingdom, India
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series A, Series B
- United States, Israel, Ireland
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Seed, Series A, Funding Round
- United States, Israel, Canada
Portfolio highlights
- Normunity — We create medicines that free normal immunity to defeat cancer using proprietary platforms that uncover novel immuno-oncology mechanisms.
- VeraDermics — VeraDermics Inc. is a dermatology pharmaceutical start-up, makers of WartPatch
- PHȲND — PHȲND is a subscription-free cloud gaming platform that offers a way to discover, play, and socialize across a wide variety of games.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Funding Round, Series C, Series A
- Israel, United States
Portfolio highlights
- Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more
Investment focus
- Health Care, Biotechnology, Mobile
- Series C, Series E, Series F
- United States, Israel
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Funding Round
- United States, Israel, Switzerland
Portfolio highlights
- Lyfegen — Lyfegen is the first of its kind, a company making value-based healthcare contracting for high-cost therapies a reality for all healthcare stakeholders.
- Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
- MetaSight Diagnostics — MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more
Investment focus
- Software, Analytics, Big Data
- Series B, Series A, Series C
- Israel, United States, India
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Funding Round, Series A
- Israel, Singapore, United Kingdom
Portfolio highlights
- AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
- Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Software
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech company that develops imaging and machine learning technologies for the early detection of pests and diseases in crops. It aims to develop autonomous high-resolution IPM systems to provide growers with detailed mapping of pests, benefits, and diseases and provide treatment recommendations to enable reduced chemical and laboruse, and improve crop quality and efficiency.The company was founded in 2018 and is headquartered in Yokneam, Illit, Israel.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more
Investment focus
- Information Technology, Health Care, Software
- Seed, Series A, Funding Round
- Israel, United States, China
Portfolio highlights
- Creednz — Creednz is a company that provides financial data management system that involves internal financial data sets.
- Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Series C
- Israel, United States
Portfolio highlights
- SoniVie — SoniVie's lead product, TIVUS, is an investigational intravascular treatment that can be performed as part of a routine right heart catheterization for patients suffering from pulmonary arterial hypertension (PAH)
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance
those businesses. We are geographyand industry agnostic.
Show more
Investment focus
- Artificial Intelligence, Software, Machine Learning
- Series A, Seed, Funding Round
- United Kingdom, United States, Israel
Portfolio highlights
- iGent — iGent AI focus on integrating advanced AI capabilities into the software development process.
- Verax AI — Seeks to be the leading provider of enterprise-grade trust solutions for Generative AI, enabling companies worldwide to build or adopt any Generative AI agent with confidence
- Prior Labs — Prior Labs is developing innovative foundation models that understand spreadsheets and databases.
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
Show more
Investment focus
- Health Care, Software, Artificial Intelligence
- Seed, Series A, Series B
- United States, Israel, India
Portfolio highlights
- OneStep — OneStep offers providers the ultimate digital physical therapy solution that enables remote therapeutic monitoring and boosts clinical outcomes.
- Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
- Phantom Neuro — Phantom Neuro is leveraging advancements in neuroscience, surgery, artificial intelligence, and robotics to make lifelike control accessible to the general population.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more
Investment focus
- Software, Cyber Security, Transportation
- Seed, Series B, Series A
- Israel, United States
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series C, Series D, Funding Round
- Israel, United States
Portfolio highlights
- MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS). The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
- Ivenix — Bring the power of guided workflows, adaptive fluid delivery, and complete secondary delivery with an Ivenix IV Infusion System. Explore now.
- Rewalk Robotics — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more
Investment focus
- Software, Health Care, Biotechnology
- Seed, Series A, Funding Round
- United States, Israel
Portfolio highlights
- Vytala — Vytala is a food tech firm focused on improving nutrition through innovative solutions.
- Proscia — Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team oftechnologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.
- S2N Health — Our superior healthcare data, industry expertise, and embedded AI inject critical intelligence into commercial workflows to drive efficient growth.
Shimon Eckhouse
Show more
Investment focus
- Medical, Biotechnology, Fitness
- Seed, Funding Round
- Israel
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Shalom Equity Fund
Show more
Investment focus
- Medical, Sensor, Health Care
- Seed, Funding Round
- Israel
Portfolio highlights
- GeneGrafts — GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias.
- VisionSense — Visionsense develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). With advanced sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. Existing MinimallyInvasive Surgery (MIS) vision solutions provide 2D (monocular) images that lack depth perception. This restricts the surgeon’s perspective limiting the ability to perform advanced MIS procedures. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand eye coordination and the confidence to use advanced (articulating) surgical tools.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Sweden, Israel, Iceland
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Series A, Series B, Series C
- United States, Israel
Portfolio highlights
- CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
- Sweetch — Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabeticpopulation, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.
- Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point.
Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Health Care
- Series A, Funding Round, Seed
- Israel, United States, Germany
Portfolio highlights
- CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
- Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more
Investment focus
- Software, Internet, Health Care
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- CADY — CADY utilizes AI technology to automate the analysis of electrical schematics
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Prof. Rafael Beyar
Show more
Investment focus
- Medical, Medical Device, Machine Learning
- Seed, Series A
- Israel
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Append Medical — A novel transcatheter LAA elimination system
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more
Investment focus
- Health Care, Medical, Artificial Intelligence
- Funding Round, Series B, Series C
- Israel, United States
Portfolio highlights
- Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Software
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
- Quantum Source — Quantum Source is on a clear path to the most powerful, cost-effective, practical photonic quantum computer. Learn more.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more
Investment focus
- Food and Beverage, Agriculture, Biotechnology
- Series A, Series B, Funding Round
- United States, Canada, Israel
Portfolio highlights
- Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
- Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
- Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Series B
- Israel, United States, Cyprus
Portfolio highlights
- SuperC AI — Connect residents and foster engagement with a centralized community calendar that brings all city events into one easy-to-access platform
- With (Coing) — Connect residents and foster engagement with a centralized community calendar that brings all city events into one easy-to-access platform
- Anchor — Freedom from the burden of invoicing and collections. One platform to make your billing cycle flow. Autonomously. Get paid on time, slash costs, and delight your customers.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Funding Round, Series A, Series D
- Israel, United States
Portfolio highlights
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
- Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
- Click Therapeutics — We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.
Group 11 invests in visionary entrepreneurs who are utilizing the unstoppable momentum of AI and FinTech to redraw the landscape of their respective industries. With a goal of creating change across generations and building long term value through technology, Group 11 has emerged as a coveted partner to veteran entrepreneurs at the forefront oftheir fields. Since its inception in 2012, the firm has deployed over $600 million across six funds in some of the world’s most prominent and disruptive technology companies, including: Tipalti, Navan, Next Insurance, HomeLight, Sunbit, Masterschool, Healthee, Dream, and BridgeWise.
Show more
Investment focus
- FinTech, Software, Financial Services
- Series A, Seed, Series B
- United States, Israel
Portfolio highlights
- Aeropay — Payment processing solutions designed to provide businesses with lower costs, faster settlement times, and enhanced security. Built to handle C2B payments and B2B payments both in-person and online. Cannabis payments.
- Healthee — Insurights is an AI-powered digital platform that allows employees to utilize their health benefits and coverage. It provides employees on-the-spot answers to their health coverage and benefits questions, helps them find lower-cost providers, and lets them know about relevant preventive care benefits to ensure they are healthier.
- Dream Security — Dream Security provides critical infrastructure defensive cyber solutions.
Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Pre-Seed, Series A
- Israel, France, United States
Portfolio highlights
- Rookout — Speed up the debugging process and accelerate your team's velocity with Rookout's live, remote debugging platform. Debug anything, anywhere. Effortlessly.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink creates the ultimate interaction between your eyes & the world around you with our eye tracking software & eye tracking technology.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.
Show more
Investment focus
- Health Care, FinTech, E-Learning
- Seed, Pre-Seed, Series A
- Israel, United States, Norway
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Vayu — Discover Vayu, the cutting-edge billing and revenue management platform designed to streamline operations and maximize efficiency for finance teams.
- Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more
Investment focus
- Software, Artificial Intelligence, Aerospace
- Seed, Funding Round, Series A
- Israel, United Kingdom, Estonia
Portfolio highlights
- EnduroSat — At EnduroSat, we engineer, build and operate exceptional satellites. Our Mission is to make space universally accessible
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, China, Israel
Portfolio highlights
- RayThera — RayThera specializes in developing breakthrough small molecule therapies for critical unmet needs in immunology. Backed by decades of drug discovery expertise, we accelerate the development process while maintaining rigorous standards.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
- Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Funding Round
- Italy, United States, United Kingdom
Portfolio highlights
- Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more
Investment focus
- Health Care, Artificial Intelligence, Medical
- Series A, Series B, Series C
- United States, United Kingdom, Spain
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Technion Seed is a seed-stage investment firm, owned jointly by four top-tier Venture Capital funds – Vertex Venture Capital, Battery Ventures (US-based), SCP-Vitalife and ProSeed – and the Technion Research & Development Foundation. Through Technion Seed, these funds invest in high market potential technological ideas and ventures, thatare still at an early stage and with very high uncertainty. The investment in such ventures – initially up to about $1,000,000 – is made both directly by the funds and indirectly through Technion Seed. The purpose of the initial investment is to enable the entrepreneurs to prove the viability of their idea. Success in the initial phase will then lead to a large round of financing by the funds, for continued growth of the venture. Technion Seed and its owners invest in a wide variety of areas, including communications, IT, internet, medical devices, renewable energy, new materials and more.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Seed, Funding Round
- Israel, United States
Portfolio highlights
- Aren — Aren is an AI-powered platform that empowers engineers and asset owners to assess and manage civil infrastructure while minimizing the risk of failure and optimizing budgets. Its technology offers a cost-effective, automated, and quantitative approach to de-risk the asset management practice using computer vision and machine learning.
- VineSight — Protect your Brand, Cause, Campaign, Organization. Spot and eliminate attacks before they go viral.
- Envizion Medical — ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision. Same technology Same team New company ENvizion Medical is now ENvue Medical. Enhanced Navigation. Expanded Vision.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.
Our golden eggs
Ayana Pharma
A late stage company with
Show more
Investment focus
- Biotechnology, Pharmaceutical, Life Science
- Seed, Series B, Series F
- Israel
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more
Investment focus
- Semiconductor, Hardware, Health Care
- Series A, Seed, Series B
- Israel, United States
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
SeedIL Ventures is a seed stage investment fund focusing on Israeli related companies in any sector except medtech/biotech and heavy Hardware.
After investment, SeedIL is committed to ensuring that portfolio companies reach their full potential by providing on-going coaching and connections through its extensive network, including the Limitedpartner's connections and intelligence.
Show more
Investment focus
- Artificial Intelligence, Software, Big Data
- Seed, Series A, Pre-Seed
- Israel, United Kingdom, Australia
Portfolio highlights
- Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
- BlinqIO — Autonomously develop and maintain flawless automation code, combining Generative AI's power with human oversight for scalable testing solutions
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.
Show more
Investment focus
- Medical, Biotechnology, Manufacturing
- Series B, Series C, Funding Round
- Israel, United States
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more
Investment focus
- Health Care, Medical, Software
- Funding Round, Series B, Seed
- Israel, United States, Australia
Portfolio highlights
- OP.GG — The Best LoL Champion Builds and Player Stats by OP.GG - Learn champion builds, runes, and counters. Search Riot ID and Tagline for stats of all game modes.
- Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more
Investment focus
- Social Impact, Recruiting, Skill Assessment
- Pre-Seed, Seed, Series A
- Israel, United States
Portfolio highlights
- TaTiO — TaTIO is delivering a smarter way to hire through competency-based sourcing that combines artificial intelligence and job experience simulations to guarantee qualified candidates.
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- Agave Health — Through programs and coaching built by a team of experts, every aspect of adult ADHD is addressed. Read more here!
As a young and dynamic company with a spirit of entrepreneurship, we look first and foremost at the vision leading the entrepreneur. We believe that we should be investing in people, before everything else. We want to be investing in companies led by entrepreneurs who are capable of envisioning and growing great companies with products and/or services meeting real market needs in large and growing markets.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Series B, Series A, Seed
- Israel, United States, Switzerland
Portfolio highlights
- Lynxight — Lynxight creates computer vision applications for underwater operations. The company offers a platform with a set of applications utilized across multiple industries: pools, aquaculture, energy, maritime security and infrastructure, among others. Powered by proprietary AI technology, Lynxight enables superior capabilities to manage safety risksand improve operational performance: object detection, measurement and recognition, behavioral analysis, action classification, trajectory optimization and anomaly modeling to predict and forewarn of unplanned situations.Lynxight is hardware agnostic and can be applied in any environment using imaging from above/below water.
- Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
- Intelligent Traffic Control — Intelligent Traffic Control is an adaptive AI-based traffic light real-time management system. It uses advance Supervised and Unsupervised Machine Learning algorithms to make a real-time analysis of the intersection situation, recognize the traffic pattern and tendencies, and changing the green light allocation per lane accordingly, assuringminimum waiting time at the intersection by maximizing the intersection capability.ITC mathematically proved that there are many traffic jams that the system can prevent. It accumulates the algorithm based on a complex mathematical equation and set of algorithms.
Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.
Show more
Investment focus
- Software, Robotics, Artificial Intelligence
- Series A, Series B, Seed
- United States, Canada, Israel
Portfolio highlights
- Also — A better way to get there.
- True Anomaly — True Anomaly Space
- Remedy Scientific — Remedy decontaminates land with scalable, AI-driven systems, advanced chemistry and precise sensors, restoring sites to their full productive potential.
We are a VC firm investing in pre-seed and seed stage startups. We back exceptional Founders building market-transforming companies.
Show more
Investment focus
- Software, Information Technology, Marketplace
- Seed, Series A, Pre-Seed
- United States, Israel, United Kingdom
Portfolio highlights
- Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
- Gizmo — AI quizzes that help you learn and remember anything
- Stoke Space — STOKE Space Technologies seamlessly connecting earth and space.
Investors by industry
Impact
Biotech
Gaming
FinTech
Google
Energy
Proptech
Marketplace
Consumer
Hardware
Artificial intelligence
Health Care
Climate
Community
EdTech
Sustainability
Venture Capital
Clean Energy
Real Estate
Financial Services
Video Games
B2B
Education
Publishing
Finance
Food and Beverage
Beauty
Infrastructure
Web3
Photography
Retail
Big Data
Organic Food
Payments
Social Media
Medical
Internet
Manufacturing
eSports
Construction
Digital Media
Art
Local
Sports
Music
Enterprise Software
Social Network
Wellness
Email
Franchise
Android
Mobile
Legal
Mobile Advertising
Platforms
Cannabis
Hospitality
Biotechnology
Travel
Fitness
Recruiting
Automotive
Medical Device
Social
Crowdfunding
Wine And Spirits
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Film
Life Science
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Germany
India
United States
Ireland
South Korea
Canada
Australia
New Zealand
Middle East
Oceania
Europe
Asia
South Africa
Armenia
Brazil
Qatar
Indonesia
Spain
China
Saudi Arabia
Finland
Estonia
Hungary
Ethiopia
Hong Kong
Georgia
Egypt
Ecuador
Denmark
France
Faroe Islands
Ghana
Croatia
Gibraltar
Bulgaria
Chile
Belize
Barbados
Costa Rica
Greece
Belgium
Bahrain
Belarus
Bermuda
Czech Republic
Algeria
Mali
Mexico
Liberia
Israel
Philippines
Malaysia
Italy
Lithuania
Liechtenstein
Kuwait
Norway
Morocco
Myanmar
Lebanon
Mauritius
Peru
Jersey
Panama
Malta
Nicaragua
Sweden
El Salvador
Uruguay
Portugal
Zambia
Ukraine
Uzbekistan
Senegal
Seychelles
Venezuela
Tajikistan
Taiwan
Serbia
Uganda
Sierra Leone
Turkey
Thailand
Tunisia
San Marino
Rwanda
Puerto Rico
Poland
Russian Federation
Tanzania
Slovenia
Zimbabwe
Togo
Dominican Republic
Azerbaijan
Nigeria
Bahamas
Namibia
Iceland
Iraq
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Albania
Pakistan
Sri Lanka
Grenada
Romania
Jordan
Argentina
Bangladesh
Vietnam
Africa
LATAM
Japan
Singapore
Kazakhstan
Kenya
Cayman Islands
Cambodia
Oman
Cyprus
Latvia
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Israel by industry
Restaurants
Oil and Gas
Transportation
Education
Crowdfunding
Financial Services
Big Data
Venture Capital
Cryptocurrency
Finance
Payments
Food and Beverage
Organic Food
Video Games
Medical
Fitness
Medical Device
Wellness
Email
Internet
Social Media
Art
Manufacturing
Android
Mobile
Blockchain
Construction
Local
Legal
Software
Digital Media
Enterprise Software
Sports
eSports
Automotive
CleanTech
Hospitality
Travel
InsurTech
Recruiting
Cannabis
Biotechnology
Enterprise
Health Care
EdTech
Sustainability
Energy
Proptech
Impact
SaaS
Artificial intelligence
Community
Hardware
Gaming
Real Estate
Retail
Social
Mobile Apps
Infrastructure
Fashion
Beauty
Web3
B2B
Photography
Publishing
Clean Energy
Renewable Energy
Biotech
Life Science
FinTech
Social Network
Platforms
Marketplace
Music
Agriculture (agtech)
Media (entertainment)
Social Impact
Machine Learning
Mobile Advertising
Consumer
Climate